Lymphatic interventions in congenital heart disease

Area of Science:

• Cardiology
• Lymphatic Medicine
• Pediatric Congenital Abnormalities

Background:

• Congenital heart disease (CHD) affects approximately 1 in 100 live births, representing a significant portion of congenital abnormalities.
• The association between CHD and lymphatic abnormalities, including dysfunction, is well-established and categorized into syndromic and non-syndromic causes.
• Syndromic cases involve primary lymphatic developmental defects, while non-syndromic lymphatic dysfunction is often secondary to CHD physiological issues and surgical interventions.

Purpose of the Study:

• To explore the relationship between congenital heart disease and lymphatic dysfunction.
• To highlight the clinical manifestations and limited therapeutic options for patients with co-existing CHD and lymphatic dysfunction.
• To emphasize the role of advanced imaging and percutaneous interventions in managing these conditions.

Main Methods:

• Review of existing literature on congenital heart disease and lymphatic abnormalities.
• Discussion of syndromic and non-syndromic etiologies of lymphatic dysfunction in CHD.
• Exploration of emerging imaging techniques and percutaneous interventional strategies.

Main Results:

• Patients with CHD exhibit a wide spectrum of lymphatic abnormalities.
• Both genetic syndromes and physiological sequelae of CHD contribute to lymphatic dysfunction.
• Limited therapeutic interventions have historically been available for these complex cases.

Conclusions:

• Advanced imaging techniques are crucial for better understanding the pathophysiology of CHD-related lymphatic dysfunction.
• Percutaneous interventions represent a promising therapeutic avenue for restoring lymphatic function in affected patients.
• Further research and development in interventional techniques are needed to improve clinical outcomes.